Roche Holding, CH1499059983

Roche Holding stock schedules October 22 sales update pre-market

Published on 10/19/2026 at 07:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Roche earns revenue through its pharmaceutical and diagnostics divisions. At Lang & Schwarz the stock trades pre-market at EUR 406.93 on October 19, 2026.

Sales update date confirmed

  • Roche scheduled its third-quarter sales presentation for October 22, 2026.
  • The virtual event is scheduled for 2:00 p.m. CEST in Basel.
  • Roche Holding stock trades pre-market at EUR 406.93 at 7:54 a.m. CEST at Lang & Schwarz on October 19, 2026.
Roche Holding AG CH0012032048 – Diagnostik-Analysegerät verarbeitet biologische Proben im modernen klinischen Labor, Illustration mit AI erstellt.

Roche Holding has scheduled its third-quarter sales presentation for October 22, 2026, according to Roche investor relations. Roche Holding stock trades pre-market at EUR 406.93 at 7:54 a.m. CEST at Lang & Schwarz on October 19, 2026.

Upcoming investor presentation

The company said the event will cover Roche's third-quarter sales and take place virtually. The presentation is scheduled for October 22, 2026, at 2:00 p.m. CEST in Basel, Switzerland, according to Roche investor relations.

Ahead of the Xetra open

The pre-market indication is being monitored before the regular Xetra session. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Roche Holding stock.

Pharmaceuticals and diagnostics

Roche earns revenue through pharmaceutical medicines and diagnostic products. The next scheduled investor event is the third-quarter sales presentation on October 22, 2026, at 2:00 p.m. CEST, according to Roche investor relations. Market context: Market report SMI.

More news and analysis on Roche Holding stock

Disclaimer...
en | CH1499059983 | ROCHE HOLDING | boerse | 70357781 | bgmi